Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ikena Oncology Inc

IKNA
Current price
1.53 USD +0.08 USD (+5.52%)
Last closed 1.5 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 72 387 152 USD
Yield for 12 month -31.39 %
Week
Month
Year
IKNA
21.11.2021 - 28.11.2021

Ikena Oncology, Inc. operates as an oncology company that develops precision medicines to biomarker-defined patients with specific unmet needs in the United States. Its lead oncology product candidate is IK-930, a paralog selective inhibitor of the transcriptional enhanced associate domain, a transcription factor in the Hippo signaling pathway. It also develops IK-595, designed to trap MEK and RAF for inhibiting RAS signals than existing inhibitors; and IK-175, a monotherapy and in combination with nivolumab in patients with advanced or metastatic solid tumors, including urothelial carcinomas. Ikena Oncology, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. Address: 645 Summer Street, Boston, MA, United States, 02210

Analytics

WallStreet Target Price

8.33 USD

P/E ratio

Dividend Yield

Current Year

+15 618 000 USD

Last Year

+30 985 000 USD

Current Quarter

+1 185 000 USD

Last Quarter

+2 004 000 USD

Current Year

+15 618 000 USD

Last Year

+30 985 000 USD

Current Quarter

+1 185 000 USD

Last Quarter

+2 004 000 USD

Key Figures IKNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -67 698 000 USD
Operating Margin TTM -1645.82 %
PE Ratio
Return On Assets TTM -21.14 %
PEG Ratio
Return On Equity TTM -36.29 %
Wall Street Target Price 8.33 USD
Revenue TTM 13 951 000 USD
Book Value 3.52 USD
Revenue Per Share TTM 0.36 USD
Dividend Share
Quarterly Revenue Growth YOY -81.5 %
Dividend Yield
Gross Profit TTM -48 703 000 USD
Earnings Share -1.62 USD
Diluted Eps TTM -1.62 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IKNA

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IKNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IKNA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.2082
Price Sales TTM 5.1887
Enterprise Value EBITDA 1.67
Price Book MRQ 0.466

Financials IKNA

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators IKNA

For 52 weeks

1.02 USD 7.64 USD
50 Day MA 3.23 USD
Shares Short Prior Month 1 277 550
200 Day MA 4.73 USD
Short Ratio 3.48
Shares Short 1 034 479
Short Percent 2.77 %